+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06477783

Observational Study on the Effectiveness of Teclistamab and Talquetamab in Relapsed or Refractory Multiple Myeloma Patients in Belgium

Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2026-09-25

100

Participants Needed

17

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the clinical effectiveness and safety of two bispecific antibodies, teclistamab and talquetamab, in patients with relapsed or refractory multiple myeloma who have already undergone at least three prior treatments. This prospective observational study is conducted in Belgium and aims to understand how these treatments perform in a real-life setting. Patients eligible for the study are those who are refractory to specific treatments including proteasome inhibitors, immunomodulatory agents, and anti-CD38 monoclonal antibodies. Participants will start treatment with either teclistamab or talquetamab as part of their routine clinical care, with some having initiated teclistamab treatment up to 28 days before screening. The study follows patients for up to 24 months or until disease progression, withdrawal, death, or loss to follow-up. During the first six months, participants have monthly follow-ups, after which data collection occurs every three months until the study ends. Throughout the study, participants will undergo regular assessments including evaluation of overall response rate, progression-free survival, overall survival, adverse events, depth and duration of response, time to response, minimal residual disease assessment at complete response, and time to next treatment. These evaluations are conducted monthly during the first six months and every three months thereafter, with the goal of monitoring patient outcomes and treatment effects over time.

CONDITIONS

Brief Title

Study on the Clinical Efficacy of Teclistamab and Talquetamab

Research Team

M

Michel Delforge, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here